Effects of endothelin receptor antagonists on anterior chamber inflammation induced by intravitreal injection of endothelin-1

Experimental Eye Research

Volumn 69, Issue 4, 1999, Pages 437-444

  Shoji, Nobuyuki ^a   Oshika, Tetsuro ^b   Amano, Shiro ^b   Masuda, Kanjiro ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANTO ROSAI HOSPITAL   (Japan)

Author keywords

Aqueous protein concentration; Endothelin 1; ET(A) receptor; ET(B) receptor; Laser flare cell meter; Leukotriene B4; Prostaglandin E2

Indexed keywords

ARACHIDONIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; LEUKOTRIENE B4; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; INFLAMMATION; LASER FLARE CELL METER; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032888386     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1999.0721     Document Type: Article

References (36)

1. 2. Curr. Eye Res. 10:1991;259-265.
2. Abdel-Latif A. A., Yousufzai S. Y. K., El-Mowafy A. M., Ye Z. Prostaglandins mediate the stimulatory effects of endothelin-1 on cyclic adenosine monophosphate accumulation in ciliary smooth muscle isolated from bovine, cat, and other mammalian species. Invest. Ophthalmol. Vis. Sci. 37:1996;328-338.
3. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
4. Bhattacherjee P., Hammond B., Salmon J. H., Stepney R., Eakins K. E. Chemotactic response to some arachidonic acid lipoxygenase product in the rabbit eye. European J. Pharmacol. 73:1981;21-28.
5. 4: A mediator of vascular permeability. Br. J. Pharmacol. 72:1981;483-486.
6. Camras C. B., Bito L. Z., Eakins K. E. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest. Ophthalmol. Vis. Sci. 16:1977;1125-1134.
7. -5m endothelin-1. Exp. Eye Res. 62:1996;605-612.
8. El-Mowafy A. M., Abdel-Latif A. A. Characterization of iris sphincter smooth muscle endothelin receptor subtypes which are coupled to cyclic AMP formation and polyphosphoinositide hydrolysis. J. Pharmacol. Exp. Ther. 268:1994;1343-1351.
9. 4) and their effects on ocular tissues. J. Eye. 5:1988;143-147.
10. Granstam E., Wang L., Bill A. Effects of endothelins (ET-1, ET-2 and ET-3) in the rabbit eye; role of prostaglandins. European J. Pharmacol. 194:1991;217-223.
11. Green K., Kim K. Pattern of ocular response to topical and systemic prostaglandin. Invest. Ophthalmol. 14:1975;36-40.
12. Areceptor-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit. Jpn. J. Ophthalmol. 40:1996;26-32.
13. Hosoda K., Nakano K., Arai H., Suga S., Ogawa Y., Mukoyama M., et al. Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett. 287:1991;23-26.
14. Areceptor. Life Sci. 50:1992;247-255.
15. Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA. 91:1994;4892-4896.
16. B2receptors, BQ-788: Effects on blood vessel and small intestine. Biochem. Biophys. Res. Commun. 205:1994;168-173.
17. Karne M., Jayawickreme C. K., Lerner M. R. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 25:1993;19126-19133.
18. 2. Jpn. J. Inflammation. 7:1987;511-515.
19. Kondoh M., Miyazaki H., Uchiyama Y., Yanagisawa Y., Masaki T., Murakami K. Solubilization of two types of endothelin receptor, ETA and ETB from rat lung with retention of binding activity. Biomed. Res. 12:1991;417-423.
20. Kurimoto F. Leukotriene. Nippon Rinsho. 48 (suppl.):1990;213-216.
21. 4. Proc. Natl. Acad. Sci. USA. 79:1982;7904-7908.
22. MacCumber M. W., Salvatore A. D. Endothelin receptor-binding subtypes in the human retina and choroid. Arch. Ophthalmol. 112:1994;1231-1235.
23. Mihara S., Nakajima S., Matumura S., Kohnoike T., Fujimoto M. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139. J. Pharmacol. Exp. Ther. 268:1994;1122-1128.
24. Mihara S., Tozawa F., Itazaki K., Fujimoto M. Binding characterization of [3H]S-0139, and antagonist of the endothelin ET(A) receptor subtype. Eur. J. Pharmacol. 342:1998;319-324.
25. Nakamuta M., Takayanagi R., Sakai Y., Sakamot S., Hagiwara H., Mizuno T., et al. Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor. Biochem. Biophys. Res. Commun. 177:1991;34-39.
26. Ogawa Y., Nakao K., Arai H., Nakagawa O., Hosoda K., Suga S., et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem. Biophys. Res. Commun. 178:1991;248-255.
27. Osborne N. N., Barnett N. L., Luttmann W. Endothelin receptors in the cornea, iris and ciliary processes. Evidence from binding, secondary messenger and PCR studies. Exp. Eye. Res. 56:1993;721-728.
28. Oshika T., Kato S., Sawa M., Masuda K. Aqueous flare intensity and age. Jpn. J. Ophthalmol. 33:1989;237-242.
29. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 20:1980;947-957.
30. Sakamoto A., Yanagisawa M., Sakurai T., Takuma Y., Yanagisawa H., Masaki T. Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem. Biophys. Res. Commun. 178:1991;656-663.
31. Sakurai T., Yanagisawa M., Takuma Y., Miyazaki H., Kimura S., Goto K., et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
32. Shoji N., Oshika T., Masuda K. Endothelin-1 and intraocular inflammation in pigmented rabbit eye. Jpn. J. Ophthalmol. 41:1997;150-153.
33. Shoji N., Oshika T., Masuda K. Inflammatory reaction via arachidonic acid cascade after intravitreal injection of endothelin-1. Curr. Eye Res. 17:1998;205-210.
34. Areceptor antagonist. J. Pharmacol. Exp. Ther. 264:1993;1040-1046.
35. Stjernschantz J., Sherk T., Borgeat P., et al. Intraocular effects of lipoxygenase pathway products in arachidonic acid metabolism. Acta Ophthalmol. 62:1983;104-111.
36. Sugiyama K., Haque S. R., Okada K., Taniguchi T., Hayakawa T., Kitazawa Y. The effect of an endothelin receptor antagonist, 97-139, on intraocular pressure in rabbits. J. Jpn. Ophthalmol. Soc. 99:1995;271-276.